Seattle Genetics Reports Fourth Quarter and Year 2016 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. NVDA
2. PCVX
3. PTC
4. SPY
5. META
6. MSFT
7. GOOGL
8. GMAB
9. AMD
10. BBIO

Go back to Seattle Genetics Reports Fourth Quarter and Year 2016 Financial Results

BofA/Merrill Lynch Downgrades Seattle Genetics (SGEN) to Underperform

February 10, 2017 8:44 AM EST

BofA/Merrill Lynch downgraded Seattle Genetics (NASDAQ: SGEN) from Neutral to Underperform.

For an analyst ratings summary and ratings history on Seattle Genetics click here. For more ratings news on Seattle Genetics click here.

Shares of Seattle Genetics closed at $62.81 yesterday.

... More

Seattle Genetics (SGEN) Misses Q4 EPS by 5c

February 9, 2017 4:26 PM EST

Seattle Genetics (NASDAQ: SGEN) reported Q4 EPS of ($0.39), $0.05 worse than the analyst estimate of ($0.34). Revenue for the quarter came in at $105.3 million versus the consensus estimate of $105.02 million.

GUIDANCE:

Seattle Genetics sees FY2017 revenue of $405-445 million.

For earnings history and earnings-related data on Seattle Genetics (SGEN) click here.

... More